Literature DB >> 28939353

Reproducibility in contouring the neurovascular bundle for prostate cancer radiation therapy.

Richard J Cassidy1, Sherif G Nour2, Tian Liu3, Jeffrey M Switchenko4, Sibo Tian3, Matthew J Ferris3, Robert H Press3, Jim Zhong3, Mustafa Abugideiri3, Peter J Rossi3, Ashesh B Jani3.   

Abstract

PURPOSE: Efforts to define the neurovascular bundle (NVB) for prostate radiation have varied. In this series, we sought to determine the reproducibility and reliability of contouring the classical posterolateral NVB on dedicated pelvic magnetic resonance imaging (MRI) scans. METHODS AND MATERIALS: A total of 120 NVB structures were defined on 10 3-Tesla pelvic MRI scans in patients with prostate cancer but without extraprostatic extension. One pelvic radiologist served as the expert in contouring the right and left NVB for each case. Five radiation oncologists, with varying levels of experience, contoured the right and left NVBs on these same cases. The intraclass correlation coefficient across each rater and the expert, Pearson correlation coefficient between each rater and the expert, and the Dice similarity coefficient (DSC) between each rater and the expert were calculated to evaluate contour agreement and overlap.
RESULTS: The overall intraclass correlation coefficient was 0.89 (95% confidence interval [CI], 0.81-0.95). The Pearson correlation coefficient was 0.95 (95% CI, 0.86-0.98) for rater 1, 0.98 (95% CI, 0.95-0.99) for rater 2, 0.94 (95% CI, 0.86-0.98) for rater 3, 0.98 (95% CI, 0.95-0.99) for rater 4, and 0.84 (95% CI, 0.63-0.93) for rater 5. The mean DSC was 0.72 (standard deviation [SD], 0.07) for rater 1, 0.72 (SD, 0.06) for rater 2, 0.73 (SD, 0.09) for rater 3, 0.74 (SD, 0.09) for rater 4, and 0.68 (SD, 0.13) for rater 5. Overall, across all raters, the average DSC was 0.72 (SD, 0.09).
CONCLUSIONS: The classic posterolateral NVB can be accurately and reliably contoured on 3-Tesla pelvic MRI scans by radiation oncologists.
Copyright © 2017 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28939353      PMCID: PMC5942224          DOI: 10.1016/j.prro.2017.08.001

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  33 in total

1.  Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma.

Authors:  John W Robinson; Sabine Moritz; Tak Fung
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-15       Impact factor: 7.038

2.  Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.

Authors:  Yolanda Pardo; Ferran Guedea; Ferrán Aguiló; Pablo Fernández; Víctor Macías; Alfonso Mariño; Asunción Hervás; Ismael Herruzo; María José Ortiz; Javier Ponce de León; Jordi Craven-Bratle; José Francisco Suárez; Ana Boladeras; Àngels Pont; Adriana Ayala; Gemma Sancho; Evelyn Martínez; Jordi Alonso; Montserrat Ferrer
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

3.  Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer.

Authors:  J Kao; J Turian; A Meyers; R J Hamilton; B Smith; S Vijayakumar; A B Jani
Journal:  Br J Radiol       Date:  2004-02       Impact factor: 3.039

4.  Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.

Authors:  A Gabriella Wernicke; Richard Valicenti; Kelly Dieva; Christopher Houser; Ed Pequignot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-12-01       Impact factor: 7.038

Review 5.  Radiation dose-volume effects and the penile bulb.

Authors:  Mack Roach; Jiho Nam; Giovanna Gagliardi; Issam El Naqa; Joseph O Deasy; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

6.  Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.

Authors:  Taku Naiki; Takehiko Okamura; Daisuke Nagata; Yuji Mori; Noriyasu Kawai; Kumiko Ogawa; Hidetoshi Akita; Yoshihiro Hashimoto; Keiichi Tozawa; Kenjiro Kohri
Journal:  Asian Pac J Cancer Prev       Date:  2011

7.  A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.

Authors:  G S Merrick; W M Butler; A T Dorsey; J H Lief; J G Donzella
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038

8.  Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy.

Authors:  Jean L Wright; Jeffrey H Newhouse; Joseph L Laguna; Darleen Vecchio; Ronald D Ennis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

Review 9.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

Review 10.  Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment.

Authors:  Cem Akbal; Ilker Tinay; Ferruh Simşek; Levent N Turkeri
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

View more
  5 in total

1.  Longitudinal Changes in U.S. Parameters of Neurovascular Bundles Suggest Mechanism for Radiation-Induced Erectile Dysfunction.

Authors:  James R Janopaul-Naylor; Tian Liu; Boran Zhou; Xiaofeng Yang; Neal S McCall; Pretesh R Patel; Akanksha Mehta; Sherif G Nour; Ashesh B Jani
Journal:  Adv Radiat Oncol       Date:  2022-03-19

2.  Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.

Authors:  Mark E Hwang; Mark Mayeda; Hiram Shaish; Carl D Elliston; Catherine S Spina; Sven Wenske; Israel Deutsch
Journal:  Br J Radiol       Date:  2021-02-15       Impact factor: 3.039

3.  Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.

Authors:  F R Teunissen; R C Wortel; F J Wessels; A Claes; S M G van de Pol; M J A Rasing; R P Meijer; H H E van Melick; J C J de Boer; H M Verkooijen; J R N van der Voort van Zyp
Journal:  Clin Transl Radiat Oncol       Date:  2021-11-14

4.  Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients.

Authors:  Frederik R Teunissen; Ruud C Wortel; Jochem Hes; Thomas Willigenburg; Eline N de Groot-van Breugel; Johannes C J de Boer; Harm H E van Melick; Helena M Verkooijen; Jochem R N van der Voort van Zyp
Journal:  Phys Imaging Radiat Oncol       Date:  2021-09-21

5.  Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.

Authors:  Frederik R Teunissen; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Helena M Verkooijen; Ruud C Wortel; Johannes C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.